Abraxis Bioscience Buys Manufacturing Complex From Pfizer

Los Angeles-based Abraxis BioScience said this week that it has completed the acquisition of a manufacturing facility in Puerto Rico from Pfizer. The firm, which develops products for the oncology, infectious disease, and critical care healthcare areas, said that the 56-acre site includes 172,000 square feet of manufacturing capabilities for injectable pharmaceuticals. The firm will begin commercial manufacturing from the site in the first half of 2007.